Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.905
Filter
1.
Hum Brain Mapp ; 45(11): e26801, 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-39087903

ABSTRACT

Damage to the posterior language area (PLA), or Wernicke's area causes cortical reorganization in the corresponding regions of the contralateral hemisphere. However, the details of reorganization within the ipsilateral hemisphere are not fully understood. In this context, direct electrical stimulation during awake surgery can provide valuable opportunities to investigate neuromodulation of the human brain in vivo, which is difficult through the non-invasive approaches. Thus, in this study, we aimed to investigate the characteristics of the cortical reorganization of the PLA within the ipsilateral hemisphere. Sixty-two patients with left hemispheric gliomas were divided into groups depending on whether the lesion extended to the PLA. All patients underwent direct cortical stimulation with a picture-naming task. We further performed functional connectivity analyses using resting-state functional magnetic resonance imaging (MRI) in a subset of patients and calculated betweenness centrality, an index of the network importance of brain areas. During direct cortical stimulation, the regions showing positive (impaired) responses in the non-PLA group were localized mainly in the posterior superior temporal gyrus (pSTG), whereas those in the PLA group were widely distributed from the pSTG to the posterior supramarginal gyrus (pSMG). Notably, the percentage of positive responses in the pSMG was significantly higher in the PLA group (47%) than in the non-PLA group (8%). In network analyses of functional connectivity, the pSMG was identified as a hub region with high betweenness centrality in both the groups. These findings suggest that the language area can spread beyond the PLA to the pSMG, a hub region, in patients with lesion progression to the pSTG. The change in the pattern of the language area may be a compensatory mechanism to maintain efficient brain networks.


Subject(s)
Brain Neoplasms , Magnetic Resonance Imaging , Nerve Net , Wernicke Area , Humans , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/physiopathology , Male , Female , Middle Aged , Adult , Wernicke Area/diagnostic imaging , Wernicke Area/physiopathology , Wernicke Area/physiology , Nerve Net/diagnostic imaging , Nerve Net/physiopathology , Glioma/diagnostic imaging , Glioma/physiopathology , Glioma/surgery , Glioma/pathology , Electric Stimulation , Aged , Language , Connectome , Parietal Lobe/diagnostic imaging , Parietal Lobe/physiopathology , Brain Mapping , Young Adult
2.
Nat Biomed Eng ; 8(6): 672-688, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38987630

ABSTRACT

The most widely used fluorophore in glioma-resection surgery, 5-aminolevulinic acid (5-ALA), is thought to cause the selective accumulation of fluorescent protoporphyrin IX (PpIX) in tumour cells. Here we show that the clinical detection of PpIX can be improved via a microscope that performs paired stimulated Raman histology and two-photon excitation fluorescence microscopy (TPEF). We validated the technique in fresh tumour specimens from 115 patients with high-grade gliomas across four medical institutions. We found a weak negative correlation between tissue cellularity and the fluorescence intensity of PpIX across all imaged specimens. Semi-supervised clustering of the TPEF images revealed five distinct patterns of PpIX fluorescence, and spatial transcriptomic analyses of the imaged tissue showed that myeloid cells predominate in areas where PpIX accumulates in the intracellular space. Further analysis of external spatially resolved metabolomics, transcriptomics and RNA-sequencing datasets from glioblastoma specimens confirmed that myeloid cells preferentially accumulate and metabolize PpIX. Our findings question 5-ALA-induced fluorescence in glioma cells and show how 5-ALA and TPEF imaging can provide a window into the immune microenvironment of gliomas.


Subject(s)
Brain Neoplasms , Glioma , Protoporphyrins , Spectrum Analysis, Raman , Protoporphyrins/metabolism , Humans , Glioma/pathology , Glioma/metabolism , Glioma/surgery , Glioma/diagnostic imaging , Spectrum Analysis, Raman/methods , Brain Neoplasms/pathology , Brain Neoplasms/metabolism , Brain Neoplasms/surgery , Brain Neoplasms/diagnostic imaging , Microscopy, Fluorescence/methods , Aminolevulinic Acid/metabolism , Female , Male
4.
Neurosurg Rev ; 47(1): 301, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38954077

ABSTRACT

Given that glioma cells tend to infiltrate and migrate along WM tracts, leading to demyelination and axonal injuries, Diffusion Tensor Imaging (DTI) emerged as a promising tool for identifying major "high-risk areas" of recurrence within the peritumoral brain zone (PBZ) or at a distance throughout the adjacents white matter tracts. Of our systematic review is to answer the following research question: In patients with brain tumor, is DTI able to recognizes within the peri-tumoral brain zone (PBZ) areas more prone to local (near the surgical cavity) or remote recurrence compared to the conventional imaging techniques?. We conducted a comprehensive literature search to identify relevant studies in line with the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) guidelines. 15 papers were deemed compatible with our research question and included. To enhance the paper's readability, we have categorized our findings into two distinct groups: the first delves into the role of DTI in detecting PBZ sub-regions of infiltration and local recurrences (n = 8), while the second group explores the feasibility of DTI in detecting white matter tract infiltration and remote recurrences (n = 7). DTI values and, within a broader framework, radiomics investigations can provide precise, voxel-by-voxel insights into the state of PBZ and recurrences. Better defining the regions at risk for potential recurrence within the PBZ and along WM bundles will allow targeted therapy.


Subject(s)
Brain Neoplasms , Diffusion Tensor Imaging , Glioma , Neoplasm Recurrence, Local , Humans , Diffusion Tensor Imaging/methods , Glioma/diagnostic imaging , Glioma/pathology , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/pathology , Neoplasm Recurrence, Local/diagnostic imaging , White Matter/diagnostic imaging , White Matter/pathology
5.
BMC Cancer ; 24(1): 818, 2024 Jul 09.
Article in English | MEDLINE | ID: mdl-38982347

ABSTRACT

BACKGROUND: Glioma is the most common primary brain tumor with high mortality and disability rates. Recent studies have highlighted the significant prognostic consequences of subtyping molecular pathological markers using tumor samples, such as IDH, 1p/19q, and TERT. However, the relative importance of individual markers or marker combinations in affecting patient survival remains unclear. Moreover, the high cost and reliance on postoperative tumor samples hinder the widespread use of these molecular markers in clinical practice, particularly during the preoperative period. We aim to identify the most prominent molecular biomarker combination that affects patient survival and develop a preoperative MRI-based predictive model and clinical scoring system for this combination. METHODS: A cohort dataset of 2,879 patients was compiled for survival risk stratification. In a subset of 238 patients, recursive partitioning analysis (RPA) was applied to create a survival subgroup framework based on molecular markers. We then collected MRI data and applied Visually Accessible Rembrandt Images (VASARI) features to construct predictive models and clinical scoring systems. RESULTS: The RPA delineated four survival groups primarily defined by the status of IDH and TERT mutations. Predictive models incorporating VASARI features and clinical data achieved AUC values of 0.85 for IDH and 0.82 for TERT mutations. Nomogram-based scoring systems were also formulated to facilitate clinical application. CONCLUSIONS: The combination of IDH-TERT mutation status alone can identify the most distinct survival differences in glioma patients. The predictive model based on preoperative MRI features, supported by clinical assessments, offers a reliable method for early molecular mutation prediction and constitutes a valuable scoring tool for clinicians in guiding treatment strategies.


Subject(s)
Biomarkers, Tumor , Brain Neoplasms , Glioma , Isocitrate Dehydrogenase , Magnetic Resonance Imaging , Telomerase , Humans , Glioma/genetics , Glioma/mortality , Glioma/diagnostic imaging , Glioma/pathology , Biomarkers, Tumor/genetics , Brain Neoplasms/genetics , Brain Neoplasms/mortality , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/pathology , Female , Male , Magnetic Resonance Imaging/methods , Isocitrate Dehydrogenase/genetics , Middle Aged , Telomerase/genetics , Mutation , Adult , Nomograms , Prognosis , Aged
6.
Acta Neurochir (Wien) ; 166(1): 292, 2024 Jul 10.
Article in English | MEDLINE | ID: mdl-38985352

ABSTRACT

BACKGROUND: Intraoperative MRI (iMRI) has emerged as a useful tool in glioma surgery to safely improve the extent of resection. However, iMRI requires a dedicated operating room (OR) with an integrated MRI scanner solely for this purpose. Due to physical or economical restraints, this may not be feasible in all centers. The aim of this study was to investigate the feasibility of using a non-dedicated MRI scanner at the radiology department for iMRI and to describe the workflow with special focus on time expenditure and surgical implications. METHODS: In total, 24 patients undergoing glioma surgery were included. When the resection was deemed completed, the wound was temporarily closed, and the patient, under general anesthesia, was transferred to the radiology department for iMRI, which was performed using a dedicated protocol on 1.5 or 3 T scanners. After performing iMRI the patient was returned to the OR for additional tumor resection or final wound closure. All procedural times, timestamps, and adverse events were recorded. RESULT: The median time from the decision to initiate iMRI until reopening of the wound after scanning was 68 (52-104) minutes. Residual tumors were found on iMRI in 13 patients (54%). There were no adverse events during the surgeries, transfers, transportations, or iMRI-examinations. There were no wound-related complications or infections in the postoperative period or at follow-up. There were no readmissions within 30 or 90 days due to any complication. CONCLUSION: Performing intraoperative MRI using an MRI located outside the OR department was feasible and safe with no adverse events. It did not require more time than previously reported data for dedicated iMRI scanners. This could be a viable alternative in centers without access to a dedicated iMRI suite.


Subject(s)
Brain Neoplasms , Glioma , Magnetic Resonance Imaging , Workflow , Humans , Glioma/surgery , Glioma/diagnostic imaging , Brain Neoplasms/surgery , Brain Neoplasms/diagnostic imaging , Middle Aged , Female , Male , Magnetic Resonance Imaging/methods , Adult , Aged , Neurosurgical Procedures/methods , Monitoring, Intraoperative/methods , Feasibility Studies , Operating Rooms
7.
Sci Rep ; 14(1): 15613, 2024 07 06.
Article in English | MEDLINE | ID: mdl-38971907

ABSTRACT

Glioblastoma is the most common and aggressive primary malignant brain tumor with poor prognosis. Novel immunotherapeutic approaches are currently under investigation. Even though magnetic resonance imaging (MRI) is the most important imaging tool for treatment monitoring, response assessment is often hampered by therapy-related tissue changes. As tumor and therapy-associated tissue reactions differ structurally, we hypothesize that biomechanics could be a pertinent imaging proxy for differentiation. Longitudinal MRI and magnetic resonance elastography (MRE) were performed to monitor response to immunotherapy with a toll-like receptor 7/8 agonist in orthotopic syngeneic experimental glioma. Imaging results were correlated to histology and light sheet microscopy data. Here, we identify MRE as a promising non-invasive imaging method for immunotherapy-monitoring by quantifying changes in response-related tumor mechanics. Specifically, we show that a relative softening of treated compared to untreated tumors is linked to the inflammatory processes following therapy-induced re-education of tumor-associated myeloid cells. Mechanistically, combined effects of myeloid influx and inflammation including extracellular matrix degradation following immunotherapy form the basis of treated tumors being softer than untreated glioma. This is a very early indicator of therapy response outperforming established imaging metrics such as tumor volume. The overall anti-tumor inflammatory processes likely have similar effects on human brain tissue biomechanics, making MRE a promising tool for gauging response to immunotherapy in glioma patients early, thereby strongly impacting patient pathway.


Subject(s)
Brain Neoplasms , Disease Models, Animal , Glioma , Immunotherapy , Magnetic Resonance Imaging , Animals , Mice , Glioma/diagnostic imaging , Glioma/therapy , Glioma/immunology , Glioma/pathology , Immunotherapy/methods , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/immunology , Brain Neoplasms/therapy , Brain Neoplasms/pathology , Magnetic Resonance Imaging/methods , Elasticity Imaging Techniques/methods , Cell Line, Tumor , Biomechanical Phenomena , Humans , Mice, Inbred C57BL , Biomarkers, Tumor/metabolism
8.
Cancer Med ; 13(14): e70016, 2024 Jul.
Article in English | MEDLINE | ID: mdl-39030882

ABSTRACT

BACKGROUND: Gliomas are recognized as the most frequent type of malignancies in the central nervous system, and efficacious prognostic indicators are essential to treat patients with gliomas and improve their clinical outcomes. The chemokine (C-C motif) ligand 2 (CCL2) is a promising predictor for glioma malignancy and progression. However, at present, the methods to evaluate CCL2 expression level are invasive and operator-dependent. OBJECTIVE: It was expected to noninvasively predict CCL2 expression levels in malignant glioma tissues by magnetic resonance imaging (MRI)-based radiomics and assess the association between the developed radiomics model and prognostic indicators and related genes. METHODS: MRI-based radiomics was used to predict CCL2 expression level using data obtained from The Cancer Imaging Archive (TCIA) and The Cancer Genome Atlas (TCGA) databases. A support vector machine (SVM)-based radiomics model and a logistic regression (LR)-based radiomics model were used to predict the radiomics score, and its correlation with CCL2 expression level was analyzed. RESULTS: The results revealed that there was an association between CCL2 expression level and the overall survival of cases with gliomas, and bioinformatics correlation analysis showed that CCL2 expression level was highly correlated with disease-related pathways, such as mTOR signaling pathway, cGMP-PKG signaling pathway, and MAPK signaling pathway. Both SVM- and LR-based radiomics data robustly predicted CCL2 expression level, and radiomics scores could also be used to predict the overall survival of patients. Moreover, the high/low radiomics scores were highly correlated with the known glioma-related genes, including CD70, CD27, and PDCD1. CONCLUSION: An MRI-based radiomics model was successfully developed, and its clinical benefits were confirmed, including the prediction of CCL2 expression level and patients' prognosis.


Subject(s)
Brain Neoplasms , Chemokine CCL2 , Glioma , Magnetic Resonance Imaging , Humans , Glioma/genetics , Glioma/diagnostic imaging , Glioma/pathology , Glioma/metabolism , Glioma/mortality , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Female , Male , Prognosis , Brain Neoplasms/genetics , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Brain Neoplasms/mortality , Magnetic Resonance Imaging/methods , Middle Aged , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Neoplasm Grading , Adult , Support Vector Machine , Gene Expression Regulation, Neoplastic , Aged
9.
BMC Med Imaging ; 24(1): 177, 2024 Jul 19.
Article in English | MEDLINE | ID: mdl-39030508

ABSTRACT

BACKGROUND: Cancer pathology shows disease development and associated molecular features. It provides extensive phenotypic information that is cancer-predictive and has potential implications for planning treatment. Based on the exceptional performance of computational approaches in the field of digital pathogenic, the use of rich phenotypic information in digital pathology images has enabled us to identify low-level gliomas (LGG) from high-grade gliomas (HGG). Because the differences between the textures are so slight, utilizing just one feature or a small number of features produces poor categorization results. METHODS: In this work, multiple feature extraction methods that can extract distinct features from the texture of histopathology image data are used to compare the classification outcomes. The successful feature extraction algorithms GLCM, LBP, multi-LBGLCM, GLRLM, color moment features, and RSHD have been chosen in this paper. LBP and GLCM algorithms are combined to create LBGLCM. The LBGLCM feature extraction approach is extended in this study to multiple scales using an image pyramid, which is defined by sampling the image both in space and scale. The preprocessing stage is first used to enhance the contrast of the images and remove noise and illumination effects. The feature extraction stage is then carried out to extract several important features (texture and color) from histopathology images. Third, the feature fusion and reduction step is put into practice to decrease the number of features that are processed, reducing the computation time of the suggested system. The classification stage is created at the end to categorize various brain cancer grades. We performed our analysis on the 821 whole-slide pathology images from glioma patients in the Cancer Genome Atlas (TCGA) dataset. Two types of brain cancer are included in the dataset: GBM and LGG (grades II and III). 506 GBM images and 315 LGG images are included in our analysis, guaranteeing representation of various tumor grades and histopathological features. RESULTS: The fusion of textural and color characteristics was validated in the glioma patients using the 10-fold cross-validation technique with an accuracy equals to 95.8%, sensitivity equals to 96.4%, DSC equals to 96.7%, and specificity equals to 97.1%. The combination of the color and texture characteristics produced significantly better accuracy, which supported their synergistic significance in the predictive model. The result indicates that the textural characteristics can be an objective, accurate, and comprehensive glioma prediction when paired with conventional imagery. CONCLUSION: The results outperform current approaches for identifying LGG from HGG and provide competitive performance in classifying four categories of glioma in the literature. The proposed model can help stratify patients in clinical studies, choose patients for targeted therapy, and customize specific treatment schedules.


Subject(s)
Algorithms , Brain Neoplasms , Color , Glioma , Neoplasm Grading , Humans , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/pathology , Brain Neoplasms/classification , Glioma/diagnostic imaging , Glioma/pathology , Glioma/classification , Diagnosis, Computer-Assisted/methods , Image Interpretation, Computer-Assisted/methods
10.
Sci Data ; 11(1): 789, 2024 Jul 17.
Article in English | MEDLINE | ID: mdl-39019912

ABSTRACT

Brain metastases (BMs) and high-grade gliomas (HGGs) are the most common and aggressive types of malignant brain tumors in adults, with often poor prognosis and short survival. As their clinical symptoms and image appearances on conventional magnetic resonance imaging (MRI) can be astonishingly similar, their accurate differentiation based solely on clinical and radiological information can be very challenging, particularly for "cancer of unknown primary", where no systemic malignancy is known or found. Non-invasive multiparametric MRI and radiomics offer the potential to identify these distinct biological properties, aiding in the characterization and differentiation of HGGs and BMs. However, there is a scarcity of publicly available multi-origin brain tumor imaging data for tumor characterization. In this paper, we introduce a multi-center, multi-origin brain tumor MRI (MOTUM) imaging dataset obtained from 67 patients: 29 with high-grade gliomas, 20 with lung metastases, 10 with breast metastases, 2 with gastric metastasis, 4 with ovarian metastasis, and 2 with melanoma metastasis. This dataset includes anonymized DICOM files alongside processed FLAIR, T1-weighted, contrast-enhanced T1-weighted, T2-weighted sequences images, segmentation masks of two tumor regions, and clinical data. Our data-sharing initiative is to support the benchmarking of automated tumor segmentation, multi-modal machine learning, and disease differentiation of multi-origin brain tumors in a multi-center setting.


Subject(s)
Brain Neoplasms , Glioma , Magnetic Resonance Imaging , Humans , Brain Neoplasms/diagnostic imaging , Glioma/diagnostic imaging , Glioma/pathology , Female , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/pathology , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/pathology , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/pathology , Melanoma/diagnostic imaging , Melanoma/pathology
11.
BMC Surg ; 24(1): 216, 2024 Jul 27.
Article in English | MEDLINE | ID: mdl-39068399

ABSTRACT

BACKGROUND: In assessing the clinical utility and safety of 3.0 T intraoperative magnetic resonance imaging (iMRI) combined with multimodality functional MRI (fMRI) guidance in the resection of functional area gliomas, we conducted a study. METHOD: Among 120 patients with newly diagnosed functional area gliomas who underwent surgical treatment, 60 were included in each group: the integrated group with iMRI and fMRI and the conventional navigation group. Between-group comparisons were made for the extent of resection (EOR), preoperative and postoperative activities of daily living based on the Karnofsky performance status, surgery duration, and postoperative intracranial infection rate. RESULTS: Compared to the conventional navigation group, the integrated navigation group with iMRI and fMRI exhibited significant improvements in tumor resection (complete resection rate: 85.0% vs. 60.0%, P = 0.006) and postoperative life self-care ability scores (Karnofsky score) (median ± interquartile range: 90 ± 25 vs. 80 ± 30, P = 0.013). Additionally, although the integrated navigation group with iMRI and fMRI required significantly longer surgeries than the conventional navigation group (mean ± standard deviation: 411.42 ± 126.4 min vs. 295.97 ± 96.48 min, P<0.0001), there was no significant between-group difference in the overall incidence of postoperative intracranial infection (16.7% vs. 18.3%, P = 0.624). CONCLUSION: The combination of 3.0 T iMRI with multimodal fMRI guidance enables effective tumor resection with minimal neurological damage.


Subject(s)
Brain Neoplasms , Glioma , Magnetic Resonance Imaging , Humans , Male , Female , Brain Neoplasms/surgery , Brain Neoplasms/diagnostic imaging , Glioma/surgery , Glioma/diagnostic imaging , Middle Aged , Magnetic Resonance Imaging/methods , Adult , Aged , Retrospective Studies , Surgery, Computer-Assisted/methods , Neuronavigation/methods , Treatment Outcome , Monitoring, Intraoperative/methods , Neurosurgical Procedures/methods
12.
Sci Rep ; 14(1): 17455, 2024 Jul 29.
Article in English | MEDLINE | ID: mdl-39075100

ABSTRACT

The first therapeutical goal followed by neurooncological surgeons dealing with prefrontal gliomas is attempting supramarginal tumor resection preserving relevant neurological function. Therefore, advanced knowledge of the frontal aslant tract (FAT) functional neuroanatomy in high-order cognitive domains beyond language and speech processing would help refine neurosurgeries, predicting possible relevant cognitive adverse events and maximizing the surgical efficacy. To this aim we performed the recently developed correlational tractography analyses to evaluate the possible relationship between FAT's microstructural properties and cognitive functions in 27 healthy subjects having ultra-high-field (7-Tesla) diffusion MRI. We independently assessed FAT segments innervating the dorsolateral prefrontal cortices (dlPFC-FAT) and the supplementary motor area (SMA-FAT). FAT microstructural robustness, measured by the tract's quantitative anisotropy (QA), was associated with a better performance in episodic memory, visuospatial orientation, cognitive processing speed and fluid intelligence but not sustained selective attention tests. Overall, the percentual tract volume showing an association between QA-index and improved cognitive scores (pQACV) was higher in the SMA-FAT compared to the dlPFC-FAT segment. This effect was right-lateralized for verbal episodic memory and fluid intelligence and bilateralized for visuospatial orientation and cognitive processing speed. Our results provide novel evidence for a functional specialization of the FAT beyond the known in language and speech processing, particularly its involvement in several higher-order cognitive domains. In light of these findings, further research should be encouraged to focus on neurocognitive deficits and their impact on patient outcomes after FAT damage, especially in the context of glioma surgery.


Subject(s)
Cognition , Diffusion Tensor Imaging , Humans , Male , Female , Cognition/physiology , Adult , Diffusion Tensor Imaging/methods , Diffusion Magnetic Resonance Imaging/methods , Middle Aged , Young Adult , Glioma/diagnostic imaging , Glioma/surgery , Glioma/pathology , Dorsolateral Prefrontal Cortex/diagnostic imaging
13.
J Integr Neurosci ; 23(7): 132, 2024 Jul 16.
Article in English | MEDLINE | ID: mdl-39082301

ABSTRACT

BACKGROUND: Non-invasive brain mapping using navigated transcranial magnetic stimulation (nTMS) is a valuable tool prior to resection of malignant brain tumors. With nTMS motor mapping, it is additionally possible to analyze the function of the motor system and to evaluate tumor-induced neuroplasticity. Distinct changes in motor cortex excitability induced by certain malignant brain tumors are a focal point of research. METHODS: A retrospective single-center study was conducted involving patients with malignant brain tumors. Clinical data, resting motor threshold (rMT), and nTMS-based tractography were evaluated. The interhemispheric rMT-ratio (rMTTumor/rMTControl) was calculated for each extremity and considered pathological if it was >110% or <90%. Distances between the corticospinal tract and the tumor (lesion-to-tract-distance - LTD) were measured. RESULTS: 49 patients were evaluated. 16 patients (32.7%) had a preoperative motor deficit. The cohort comprised 22 glioblastomas (44.9%), 5 gliomas of Classification of Tumors of the Central Nervous System (CNS WHO) grade 3 (10.2%), 6 gliomas of CNS WHO grade 2 (12.2%) and 16 cerebral metastases (32.7%). 26 (53.1%) had a pathological rMT-ratio for the upper extremity and 35 (71.4%) for the lower extremity. All patients with tumor-induced motor deficits had pathological interhemispheric rMT-ratios, and presence of tumor-induced motor deficits was associated with infiltration of the tumor to the nTMS-positive cortex (p = 0.04) and shorter LTDs (all p < 0.021). Pathological interhemispheric rMT-ratio for the upper extremity was associated with cerebral metastases, but not with gliomas (p = 0.002). CONCLUSIONS: Our study underlines the diagnostic potential of nTMS motor mapping to go beyond surgical risk stratification. Pathological alterations in motor cortex excitability can be measured with nTMS mapping. Pathological cortical excitability was more frequent in cerebral metastases than in gliomas.


Subject(s)
Brain Neoplasms , Diffusion Tensor Imaging , Motor Cortex , Pyramidal Tracts , Transcranial Magnetic Stimulation , Humans , Pyramidal Tracts/physiopathology , Pyramidal Tracts/diagnostic imaging , Pyramidal Tracts/pathology , Brain Neoplasms/physiopathology , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/pathology , Motor Cortex/physiopathology , Motor Cortex/diagnostic imaging , Motor Cortex/pathology , Male , Female , Middle Aged , Retrospective Studies , Adult , Aged , Glioma/physiopathology , Glioma/pathology , Glioma/diagnostic imaging , Brain Mapping , Evoked Potentials, Motor/physiology
14.
Radiol Artif Intell ; 6(4): e230254, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38984985

ABSTRACT

Purpose To develop, externally test, and evaluate clinical acceptability of a deep learning pediatric brain tumor segmentation model using stepwise transfer learning. Materials and Methods In this retrospective study, the authors leveraged two T2-weighted MRI datasets (May 2001 through December 2015) from a national brain tumor consortium (n = 184; median age, 7 years [range, 1-23 years]; 94 male patients) and a pediatric cancer center (n = 100; median age, 8 years [range, 1-19 years]; 47 male patients) to develop and evaluate deep learning neural networks for pediatric low-grade glioma segmentation using a stepwise transfer learning approach to maximize performance in a limited data scenario. The best model was externally tested on an independent test set and subjected to randomized blinded evaluation by three clinicians, wherein they assessed clinical acceptability of expert- and artificial intelligence (AI)-generated segmentations via 10-point Likert scales and Turing tests. Results The best AI model used in-domain stepwise transfer learning (median Dice score coefficient, 0.88 [IQR, 0.72-0.91] vs 0.812 [IQR, 0.56-0.89] for baseline model; P = .049). With external testing, the AI model yielded excellent accuracy using reference standards from three clinical experts (median Dice similarity coefficients: expert 1, 0.83 [IQR, 0.75-0.90]; expert 2, 0.81 [IQR, 0.70-0.89]; expert 3, 0.81 [IQR, 0.68-0.88]; mean accuracy, 0.82). For clinical benchmarking (n = 100 scans), experts rated AI-based segmentations higher on average compared with other experts (median Likert score, 9 [IQR, 7-9] vs 7 [IQR 7-9]) and rated more AI segmentations as clinically acceptable (80.2% vs 65.4%). Experts correctly predicted the origin of AI segmentations in an average of 26.0% of cases. Conclusion Stepwise transfer learning enabled expert-level automated pediatric brain tumor autosegmentation and volumetric measurement with a high level of clinical acceptability. Keywords: Stepwise Transfer Learning, Pediatric Brain Tumors, MRI Segmentation, Deep Learning Supplemental material is available for this article. © RSNA, 2024.


Subject(s)
Brain Neoplasms , Deep Learning , Magnetic Resonance Imaging , Humans , Child , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/pathology , Magnetic Resonance Imaging/methods , Male , Adolescent , Child, Preschool , Retrospective Studies , Female , Infant , Young Adult , Glioma/diagnostic imaging , Glioma/pathology , Image Interpretation, Computer-Assisted/methods
15.
Mol Imaging ; 23: 15353508241261583, 2024.
Article in English | MEDLINE | ID: mdl-38952400

ABSTRACT

Objective: To investigate the performance of diffusion-tensor imaging (DTI) and hydrogen proton magnetic resonance spectroscopy (1H-MRS) parameters in predicting the immunohistochemistry (IHC) biomarkers of glioma. Methods: Patients with glioma confirmed by pathology from March 2015 to September 2019 were analyzed, the preoperative DTI and 1H-MRS images were collected, apparent diffusion coefficient (ADC) and fractional anisotropy (FA), in the lesion area were measured, the relative values relative ADC (rADC) and relative FA (rFA) were obtained by the ratio of them in the lesion area to the contralateral normal area. The peak of each metabolite in the lesion area of 1H-MRS image: N-acetylaspartate (NAA), choline (Cho), and creatine (Cr), and metabolite ratio: NAA/Cho, NAA/(Cho + Cr) were selected and calculated. The preoperative IHC data were collected including CD34, Ki-67, p53, S-100, syn, vimentin, NeuN, Nestin, and glial fibrillary acidic protein. Results: One predicting parameter of DTI was screened, the rADC of the Ki-67 positive group was lower than that of the negative group. Two parameters of 1H-MRS were found to have significant reference values for glioma grades, the NAA and Cr decreased as the grade of glioma increased, moreover, Ki-67 Li was negatively correlated with NAA and Cr. Conclusion: NAA and Cr have potential application value in predicting glioma grades and tumor proliferation activity. Only rADC has predictive value for Ki-67 expression among DTI parameters.


Subject(s)
Brain Neoplasms , Glioma , Immunohistochemistry , Humans , Glioma/diagnostic imaging , Glioma/pathology , Glioma/metabolism , Male , Female , Middle Aged , Adult , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/pathology , Brain Neoplasms/metabolism , Diffusion Tensor Imaging/methods , Magnetic Resonance Imaging/methods , Aged , Proton Magnetic Resonance Spectroscopy/methods , Young Adult
16.
BMC Cancer ; 24(1): 805, 2024 Jul 05.
Article in English | MEDLINE | ID: mdl-38969990

ABSTRACT

BACKGROUND: Differentiation of glioma and solitary brain metastasis (SBM), which requires biopsy or multi-disciplinary diagnosis, remains sophisticated clinically. Histogram analysis of MR diffusion or molecular imaging hasn't been fully investigated for the differentiation and may have the potential to improve it. METHODS: A total of 65 patients with newly diagnosed glioma or metastases were enrolled. All patients underwent DWI, IVIM, and APTW, as well as the T1W, T2W, T2FLAIR, and contrast-enhanced T1W imaging. The histogram features of apparent diffusion coefficient (ADC) from DWI, slow diffusion coefficient (Dslow), perfusion fraction (frac), fast diffusion coefficient (Dfast) from IVIM, and MTRasym@3.5ppm from APTWI were extracted from the tumor parenchyma and compared between glioma and SBM. Parameters with significant differences were analyzed with the logistics regression and receiver operator curves to explore the optimal model and compare the differentiation performance. RESULTS: Higher ADCkurtosis (P = 0.022), frackurtosis (P<0.001),and fracskewness (P<0.001) were found for glioma, while higher (MTRasym@3.5ppm)10 (P = 0.045), frac10 (P<0.001),frac90 (P = 0.001), fracmean (P<0.001), and fracentropy (P<0.001) were observed for SBM. frackurtosis (OR = 0.431, 95%CI 0.256-0.723, P = 0.002) was independent factor for SBM differentiation. The model combining (MTRasym@3.5ppm)10, frac10, and frackurtosis showed an AUC of 0.857 (sensitivity: 0.857, specificity: 0.750), while the model combined with frac10 and frackurtosis had an AUC of 0.824 (sensitivity: 0.952, specificity: 0.591). There was no statistically significant difference between AUCs from the two models. (Z = -1.14, P = 0.25). CONCLUSIONS: The frac10 and frackurtosis in enhanced tumor region could be used to differentiate glioma and SBM and (MTRasym@3.5ppm)10 helps improving the differentiation specificity.


Subject(s)
Brain Neoplasms , Glioma , Humans , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/secondary , Brain Neoplasms/pathology , Glioma/diagnostic imaging , Glioma/pathology , Female , Male , Middle Aged , Adult , Diagnosis, Differential , Aged , Diffusion Magnetic Resonance Imaging/methods , ROC Curve , Magnetic Resonance Imaging/methods
17.
Clin Ter ; 175(4): 239-245, 2024.
Article in English | MEDLINE | ID: mdl-39010808

ABSTRACT

Purpose: This study aimed to investigate the role of 3 Tesla Dif-fusion tensor imaging (DTI) in the assessment of brainstem glioma (BSG) grading. Materials and methods: The study comprised 22 patients, including pathology-proven 6 brainstem low-grade gliomas (BS-LGG) and 16 brainstem high-grade gliomas (BS-HGG). Characteristics including age, gender, fractional anisotropy (FA), mean diffusivity (MD) of the tumor, peritumoral region, and the ratio of tumor FA to parenchymal FA, as well as tumor MD to parenchymal MD (rFA and rMD), were compared using Mann-Whitney U test, Shapiro-Wilk test, and Chi-square test. Receiver operating characteristic (ROC) curve analysis was used in the study to determine cut-off values and diagnostic values for grading brainstem gliomas (BSG) using diffusion tensor imaging (DTI). Results: Our study revealed no significant difference in age and gender between the BS-LGG and BS-HGG groups (p>0.05). Fractional anisotropy (FA) indices on DTI MRI were found to be highly valuable in grading BSG, with an area under the curve (AUC) of 0.958 - 0.979 when using cut-off values of tFA, pFA, rtFA, and rpFA at 0.318, 0.378, 0.424, and 0.517, respectively. Particularly, rtFA demonstrated the hi-ghest diagnostic value with a sensitivity (Se) of 100%, specificity (Sp) of 93.8%, and AUC of 0.079. Conversely, the indices of tumor mean diffusivity (tMD), peritumoral edema region mean diffusivity (pMD), rtMD, and rpMD showed no diagnostic value in grading BSG. Conclusion: The fractional anisotropy (FA) value on DTI between the tumor region and normal brain parenchyma holds significant value in diagnosing brainstem gliomas (BSG) grading, thereby playing a crucial role in treatment planning and predicting outcomes for patients with brainstem gliomas.


Subject(s)
Brain Stem Neoplasms , Diffusion Tensor Imaging , Glioma , Neoplasm Grading , Humans , Glioma/diagnostic imaging , Glioma/pathology , Diffusion Tensor Imaging/methods , Male , Female , Adult , Middle Aged , Brain Stem Neoplasms/diagnostic imaging , Brain Stem Neoplasms/pathology , Young Adult , Anisotropy , Retrospective Studies
18.
Pharmacol Res ; 206: 107308, 2024 Aug.
Article in English | MEDLINE | ID: mdl-39019336

ABSTRACT

Glioma is the most common intracranial malignant tumor, with severe difficulty in treatment and a low patient survival rate. Due to the heterogeneity and invasiveness of tumors, lack of personalized clinical treatment design, and physiological barriers, it is often difficult to accurately distinguish gliomas, which dramatically affects the subsequent diagnosis, imaging treatment, and prognosis. Fortunately, nano-delivery systems have demonstrated unprecedented capabilities in diagnosing and treating gliomas in recent years. They have been modified and surface modified to efficiently traverse BBB/BBTB, target lesion sites, and intelligently release therapeutic or contrast agents, thereby achieving precise imaging and treatment. In this review, we focus on nano-delivery systems. Firstly, we provide an overview of the standard and emerging diagnostic and treatment technologies for glioma in clinical practice. After induction and analysis, we focus on summarizing the delivery methods of drug delivery systems, the design of nanoparticles, and their new advances in glioma imaging and treatment in recent years. Finally, we discussed the prospects and potential challenges of drug-delivery systems in diagnosing and treating glioma.


Subject(s)
Brain Neoplasms , Drug Delivery Systems , Glioma , Humans , Glioma/drug therapy , Glioma/diagnostic imaging , Glioma/diagnosis , Brain Neoplasms/drug therapy , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/diagnosis , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/therapeutic use , Nanoparticles , Blood-Brain Barrier/metabolism , Blood-Brain Barrier/drug effects , Nanoparticle Drug Delivery System
19.
Medicina (B Aires) ; 84(3): 592-596, 2024.
Article in Spanish | MEDLINE | ID: mdl-38907981

ABSTRACT

The frontal aslant tract (FAT) connects the supplementary motor area (SMA) with the pars opercularis. Its role in language and its implications in glioma surgery remain under discussion. We present an anatomosurgical study of three cases with surgical resolution. Three patients with gliomas in the left frontal lobe were operated on using an awake patient protocol with cortical and subcortical mapping techniques, conducting motor and language evaluations. Tractography was performed using DSI Studio software. All three patients showed intraoperative language inhibition through subcortical stimulation of the FAT. Resection involving the FAT correlated with language deficits in all cases and movement initiation deficits in two cases. All patients recovered from their deficits at six months postoperatively. In conclusion, the tract has been successfully reconstructed, showing both anatomical and functional complexity, supporting the idea of its mapping and preservation in glioma surgery. Future interdisciplinary studies are necessary to determine the transient or permanent nature of the deficits.


El tracto oblicuo frontal (TOF) conecta el área motora suplementaria (AMS) con la pars opercularis. Su rol en el lenguaje y su implicancia en la cirugía de gliomas siguen en discusión. Presentamos un estudio anatomoquirúrgico de tres casos con resolución quirúrgica. Se operaron tres pacientes con gliomas en el lóbulo frontal izquierdo utilizando protocolo de paciente despierto con técnicas de mapeo cortical y subcortical realizando evaluación motora y del lenguaje. Las tractografías fueron realizadas con el software DSI Studio. Los tres pacientes presentaron inhibición intraoperatoria del lenguaje mediante la estimulación subcortical de TOF. La resección en contacto con el TOF se correlacionó con déficits del lenguaje en todos los casos y en dos casos déficits en la iniciación del movimiento. Todos los pacientes recuperaron su déficit a los seis meses postoperatorios. En conclusión, se ha logrado reconstruir al tracto. Éste presenta una complejidad anatómica y funcional, que apoya la idea de su mapeo y preservación en la cirugía de gliomas. Futuros estudios interdisciplinarios son necesarios para determinar el carácter transitorio o permanente de los déficits.


Subject(s)
Brain Neoplasms , Frontal Lobe , Glioma , Humans , Brain Neoplasms/surgery , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/pathology , Glioma/surgery , Glioma/diagnostic imaging , Glioma/pathology , Male , Frontal Lobe/surgery , Frontal Lobe/diagnostic imaging , Middle Aged , Female , Adult , Neurosurgical Procedures/methods , Brain Mapping/methods , Motor Cortex/diagnostic imaging , Motor Cortex/surgery , Motor Cortex/anatomy & histology , Diffusion Tensor Imaging
20.
Radiologia (Engl Ed) ; 66(3): 260-277, 2024.
Article in English | MEDLINE | ID: mdl-38908887

ABSTRACT

The 2021 World Health Organization classification of CNS tumours was greeted with enthusiasm as well as an initial potential overwhelm. However, with time and experience, our understanding of its key aspects has notably improved. Using our collective expertise gained in neuro-oncology units in hospitals in different countries, we have compiled a practical guide for radiologists that clarifies the classification criteria for diffuse gliomas in adults. Its format is clear and concise to facilitate its incorporation into everyday clinical practice. The document includes a historical overview of the classifications and highlights the most important recent additions. It describes the main types in detail with an emphasis on their appearance on imaging. The authors also address the most debated issues in recent years. It will better prepare radiologists to conduct accurate presurgical diagnoses and collaborate effectively in clinical decision making, thus impacting decisions on treatment, prognosis, and overall patient care.


Subject(s)
Brain Neoplasms , Glioma , Humans , Glioma/diagnostic imaging , Brain Neoplasms/diagnostic imaging , Adult , World Health Organization , Preoperative Care
SELECTION OF CITATIONS
SEARCH DETAIL